Novo Nordisk ( NVO) announced a new cash-pay option for its blockbuster weight-loss drug Wegovy, offering a monthly dose at $499 and home delivery. The move follows competitor Eli Lilly ( LLY ), which ...

Novo Nordisk is cutting the price of its weight-loss drug, Wegovy, and selling it through a direct-to-patient online pharmacy ...

Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is ...

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss that can increase the ...

Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound result in both fat and muscle loss that can increase the risk ...

The drugs are being tested to complement or replace the wildly popular Wegovy from Novo Nordisk and Eli Lilly’s Zepbound, which in trials helped patients lose 15% to 20% of their weight ...

Eli Lilly (NYSE:LLY), for example, the manufacturer of fast-growing diabetes and weight-loss drugs Mounjaro and Zepbound, could see costs increase because the active ingredients used in the ...

Weight-loss drugs are increasingly popular among employees but weigh heavily on health-insurance budgets. Popular weight-loss drugs such as Ozempic, Wegovy and Zepbound are a growing factor in ...